Detailed Information

Cited 7 time in webofscience Cited 7 time in scopus
Metadata Downloads

Off-label use of plastic syringes with silicone oil for intravenous infusion bags of antibodies

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Nam Ah-
dc.contributor.authorHada, Shavron-
dc.contributor.authorKim, Dong Jun-
dc.contributor.authorChoi, Du Hyung-
dc.contributor.authorJeong, Seong Hoon-
dc.date.accessioned2024-08-08T09:31:28Z-
dc.date.available2024-08-08T09:31:28Z-
dc.date.issued2021-09-
dc.identifier.issn0939-6411-
dc.identifier.issn1873-3441-
dc.identifier.urihttps://scholarworks.dongguk.edu/handle/sw.dongguk/20916-
dc.description.abstractThe formation of particulates in post-manufacture biopharmaceuticals continues to be a major concern in medical treatment. This study was designed to evaluate the content of micro-sized particles using flow imaging of antibodies in intravenous infusion bags. Intravenous immunoglobulin (IVIG) and Avastin (R) were selected as model drugs and plastic syringes with and without silicone oil (SO) were used to transfer the drugs into the bags (0.9% saline or 5% dextrose). Antibodies exposed to SO had significantly increased levels of microparticles in both diluents, suggesting SO accelerates particle formation, especially at a higher antibody concentration. Even before the drop stress, their count exceeded the USP guideline. Dropping the bags in the presence of SO produced larger microparticles. Meanwhile, air bubbles were retained longer in saline suggesting more protein film formation on its air-water interface. Overall, both drugs were conformationally stable and produced less particles in dextrose than in saline.-
dc.format.extent11-
dc.language영어-
dc.language.isoENG-
dc.publisherELSEVIER-
dc.titleOff-label use of plastic syringes with silicone oil for intravenous infusion bags of antibodies-
dc.typeArticle-
dc.publisher.location네델란드-
dc.identifier.doi10.1016/j.ejpb.2021.07.001-
dc.identifier.scopusid2-s2.0-85109462531-
dc.identifier.wosid000676615700003-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v.166, pp 205 - 215-
dc.citation.titleEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS-
dc.citation.volume166-
dc.citation.startPage205-
dc.citation.endPage215-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordPlusAGITATION-INDUCED AGGREGATION-
dc.subject.keywordPlusMONOCLONAL-ANTIBODY-
dc.subject.keywordPlusSUBVISIBLE PARTICLES-
dc.subject.keywordPlusPROTEIN AGGREGATION-
dc.subject.keywordPlusCOLLOIDAL STABILITY-
dc.subject.keywordPlusIONIC-STRENGTH-
dc.subject.keywordPlusHUMAN PLASMA-
dc.subject.keywordPlusIMMUNOGENICITY-
dc.subject.keywordPlusFORMULATIONS-
dc.subject.keywordPlusSURFACE-
dc.subject.keywordAuthorSubvisible particle-
dc.subject.keywordAuthorSilicone oil-
dc.subject.keywordAuthorIV infusion-
dc.subject.keywordAuthorIVIG-
dc.subject.keywordAuthorAvastin (R)-
dc.subject.keywordAuthorFlow imaging-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Pharmacy > Department of Pharmacy > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE